PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that 24 abstracts on Orencia (abatacept) and related immunoscience data will be presented at the 2015 annual meeting of the American College of Rheumatology (ACR), to be held November 6-11, in San Francisco, CA. The data being presented reinforce the company’s continued commitment to further research in moderate to severe rheumatoid arthritis (RA) and other immune-related diseases.
Help employers find you! Check out all the jobs and post your resume.
